Pursuant to Regulation 29 and 47 of SEBI Listing Regulations, 2015, Vasundhara Rasayans has informed that a meeting of Board of Directors is scheduled to be held on Tuesday, 13th August, 2019, to consider and approve the Unaudited Financial Results of the Company for the Quarter ended 30th June, 2019. Further, in continuation to its letter dated. 29.06.2019, it is hereby informed that the Trading Window shall continue to remain closed for Designated and Connected Persons, along with their immediate relatives, till 48 hours after the declaration of Financial Results as mentioned above.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.00 |
| Dr. Reddys Lab | 1215.55 |
| Cipla | 1226.00 |
| Zydus Lifesciences | 928.65 |
| Lupin | 2298.85 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: